Patent ID: 9421370
Filing Date: 2016-08-23
CPC Classification: A61B,A61N

Claim Text:
1. An electrotherapeutic treatment system, comprising: (a) at least one skin contact element including a first electrode for measurement of bioreactance at biologically active neurological points (BANP) of a tissue or organ to be treated, including monitoring of electromagnetic parameters received at said points and means for generating corrective parameters responsive to those measured; (b) a second electrode, situated on the abdomen proximally to a tissue or organ to be treated, for neurologically transmitting bioreactive parameters at said BANP of said tissues or organs, said parameters modifying discrete reactive values responsive to those measured by each of the said first and second electrodes responsive to abnormal parameters received from tissues or organs to be treated at said BANP, in which said first and second electrodes respectively comprise: a first transmitting means proportioned for application to a dorsal surface of a spinal cord situated at vertebrae having a neurological association with an organ or tissue to be treated; and a second transmitting means positioned against a location upon an abdomen or other external area of a patient, said location physically proximal to a tissue or organ to be treated; (c) at least one of said probes including a substantially spiral conductive core having an elongate axis and a flow of electrical current therethrough, said current producing a substantially concentric magnetic field about said axis of said conductive core, said probe emitting an axially projecting magnetic field at a distal end thereof to said BANP of said tissue or organ, said at least one probe defining at least one of said means for neurological transmission; and (d) an electrical pulse train applied at said end of a first probe emitting a pulsed magnetic field at an end of a first probe and said pulsed train also applied at a distal end of a second probe, parameters of each said pulsed magnetic fields responsive to abnormal bioreactive parameters and generating corrective parameters responsive to those abnormal parameters measured, said probes defining said first and second electrodes respectively.